Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares (688796)
SSE
134.27
+7.69 (+6.08%)
Closed
Sep 18, 2026
Day's Range
128.20137.90
52 wk Range
48.06154.99
Financial Statements - 688796 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
Revenue
1.37B▲ 40.6%
Net Income
173.19M▲ 416.4%Net Margin 12.6%
EBITDA
416.49M▲ 36.9%
Free Cash Flow
282.43M▲ 62.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 1.37B | 980.45M | 716.91M | 533.88M |
| Cost of Goods | 333.21M | 218.93M | 210.87M | 142.13M |
| Gross Profit | 1.04B | 761.51M | 506.03M | 391.75M |
 Operating Expense | - | - | - | - |
| Operating Income | 278.59M | 150.20M | -301.18M | -606M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 188.03M | 42.94M | -380.15M | -601.35M |
| Income Tax | 14.83M | 9.40M | 2.79M | 804K |
| Net Income | 173.19M | 33.53M | -382.95M | -602.15M |
| EPS Basic | 0.43 | 0.08 | -0.96 | - |
| EPS Diluted | 0.43 | 0.08 | -0.96 | - |
| Basic Shares Outstanding | 400.07M | 398.01M | 398.31M | - |
| Diluted Shares Outstanding | 400.07M | 398.01M | 398.31M | - |
| Ebit | 259.03M | 134.61M | -280.31M | -545.21M |
| Ebitda | 416.49M | 304.14M | -99.84M | -417.23M |
| Net Income Continuous Operations | 188.03M | 42.94M | -380.15M | -601.35M |
| Minority Interests | 0 | 5K | 1K | 212K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
